Investor Relations & Capital Introduction in Lyon

Lyon is France's third-largest city and the centre of one of Europe's strongest regional economies, with leading positions in life sciences, chemicals, digital and industry. For founders in biotechnology, health and industrial technology, it offers major corporate partners and experienced regional investors.

Why Lyon Matters for Capital Raising

Lyon is one of Europe's leading centres of vaccines and diagnostics, with bioMérieux, founded in 1963, headquartered nearby and Sanofi running major vaccine operations in the city.

Interpol has been headquartered in Lyon since 1989, and the city is a major centre of chemicals, energy and industrial engineering.

Lyon's universities, engineering schools and the emlyon business school supply technical and management talent, and the city has a strong regional venture and private equity community.

What Lyon Investors Examine

For life sciences businesses, scientific data, regulatory pathways and intellectual property are examined closely.

For industrial businesses, customer validation and capital efficiency receive detailed attention.

Engagement and Access

GCN connects founders with Lyon regional funds, corporate investors and family offices, alongside the Paris investor community, through conference programming and private sessions across France.

Sectors where we see consistent Lyon interest include biotechnology and diagnostics, health technology, chemicals and materials, industrial technology and software.

Partner with Global Capital Network

Whether you are raising into Lyon or allocating from it, our team can discuss how our investor relations infrastructure applies to your objectives.